sorbitan monostearate has been researched along with Psoriasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, Z; Liu, Z; Meng, S; Sun, L; Wang, L; Wang, Z; Xi, L; Zheng, Y | 1 |
| El-Gogary, RI; Elmowafy, E; Nasr, M; Ragai, MH | 1 |
| Abdelbary, AA; AbouGhaly, MH | 1 |
1 trial(s) available for sorbitan monostearate and Psoriasis
| Article | Year |
|---|---|
Novel antipsoriatic fluidized spanlastic nanovesicles: In vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy.
Topics: Administration, Cutaneous; Adult; Animals; Dermatologic Agents; Eucalyptol; Female; Hexoses; Humans; Male; Middle Aged; Nanostructures; Nicotinic Acids; Polysorbates; Psoriasis; Rats; Skin; Skin Absorption; Treatment Outcome; Young Adult | 2019 |
2 other study(ies) available for sorbitan monostearate and Psoriasis
| Article | Year |
|---|---|
Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Biomarkers; Cholesterol; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Female; Hexoses; Imiquimod; Interferon Inducers; Interleukins; Liposomes; Mice; Mice, Inbred C57BL; Pentacyclic Triterpenes; Plant Extracts; Psoriasis; Skin; Spleen; Tripterygium; Triterpenes | 2019 |
Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Topics: Administration, Cutaneous; Animals; Area Under Curve; Chemistry, Pharmaceutical; Cholesterol; Dermatologic Agents; Drug Carriers; Hexoses; Liposomes; Male; Methotrexate; Microscopy, Electron, Transmission; Models, Statistical; Nanotechnology; Organophosphates; Particle Size; Psoriasis; Rats, Wistar; Skin; Skin Absorption; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2015 |